Study to Assess the Safety and Effectiveness of Beltaven® in Patients With Allergy to Apis Mellifera, Polistes Dominula or Vespula Spp.

Safety and Dose Ranging Study of Acellular Pertussis and Acellular Pertussis -Tetanus-Diphtheria Booster Vaccines in Healthy Adults Ages 18 to 40 Years

NCT01529645 ·Status: COMPLETED ·Phase: PHASE1

Safety and Immunogenicity of Intranasal BPZE1 Vaccination in Healthy Adults

NCT03541499 ·Status: COMPLETED ·Phase: PHASE2

REVAXIS® Versus DT Polio® as a Second Booster in 6 Year-old Children

NCT00447525 ·Status: COMPLETED ·Phase: PHASE3

Study Of The Long Term Outcome Of Tuberculous Meningitis In Vietnamese Adults Treated With Adjunctive Dexamethasone

NCT01317654 ·Status: COMPLETED

Immunogenicity and Safety of Booster Dose of BoostrixTM Polio Vaccine in Previously Boosted Adults

NCT01323959 ·Status: COMPLETED ·Phase: PHASE4

Immunogenicity and Safety of BoostrixTM Using a New Syringe in 10 to 15-year Old Adolescents

NCT01362322 ·Status: COMPLETED ·Phase: PHASE4

Study Evaluating the Safety of a Recombinant Acellular Pertussis Vaccine in Adults

NCT06798831 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Study of DTap-IPV Compared to DAPTACEL® and IPOL® as the 5th Dose in Children 4 to 6 Years of Age

NCT01346293 ·Status: COMPLETED ·Phase: PHASE3

Safety of REPEVAX® Given One Month After REVAXIS®

NCT00400309 ·Status: COMPLETED ·Phase: PHASE3

Persistency Study After aP / Tdap Booster Vaccines in Adult Subjects (V113_01 Extension 1)

NCT02382913 ·Status: COMPLETED ·Phase: PHASE1

Follow-up of the EPITOPE Study to Evaluate Long-term Efficacy and Safety of DBV712 in Young Children

NCT03859700 ·Status: COMPLETED ·Phase: PHASE3

Immunogenicity and Reactogenicity Study of BoostrixTM (dTpa) and Boostrix-IPV (dTpa-IPV)

NCT01294605 ·Status: COMPLETED ·Phase: PHASE4

Allergy and COVID-19 Vaccines

NCT05028257 ·Status: COMPLETED ·Phase: PHASE3

Studies of In Vitro B Lymphocyte Responses in Subjects Receiving Tetanus Toxoid Booster Immunization

NCT00001173 ·Status: COMPLETED

10-year Follow-up After a Single Dose Acellular Pertussis Vaccination

NCT06803524 ·Status: RECRUITING ·Phase: PHASE4

Safety and Immunogenicity of DAPTACEL® as 5th Dose in Children 4 to 6 Years Old After 4 Doses of Pentacel™ or DAPTACEL®

NCT00258895 ·Status: COMPLETED ·Phase: PHASE3

Safety and Immunogenicity of Tdap Vaccine Compared to DTaP Vaccine in Children 4 to 6 Years of Age

NCT00467519 ·Status: COMPLETED ·Phase: PHASE3

Immunogenicity & Reactogenicity of Boostrix 10 Years After Previous Booster Vaccination.

NCT00610168 ·Status: COMPLETED ·Phase: PHASE4

Persistence and Long-Term Protection of Vi Antibodies Induced by Vi-DT Conjugate Vaccines in Indonesian

NCT04741828 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Safety and Immunogenicity of a Booster Dose of GSK Biological's Boostrix-Polio Vaccine

NCT00635128 ·Status: COMPLETED ·Phase: PHASE4

Persistence Study of GSK Biologicals' Tdap Vaccine 1, 3, 5 and 9 Years Following Administration as an Initial Single Dose in Healthy Young Adults and to Evaluate the Immunogenicity and Safety of Boostrix as a Second Dose of Tdap, When Administered at Year 9

NCT00489970 ·Status: COMPLETED ·Phase: PHASE3

A Combined Tdap Vaccine Used As A Booster Compared To Licensed Td Vaccine

NCT00109330 ·Status: COMPLETED ·Phase: PHASE3

Dengue Effectiveness Study in the Philippines

NCT03803618 ·Status: COMPLETED

Reducing Delay in Vaccination of Children: Logistic Barriers

NCT03516682 ·Status: COMPLETED ·Phase: NA

Study of Reduced-antigen-content Acellular Pertussis Vaccine and Diphtheria-Tetanus-Acellular Pertussis Vaccine

NCT01262924 ·Status: COMPLETED ·Phase: PHASE3